Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Supplement GMP Roundtable

This article was originally published in The Tan Sheet

Executive Summary

Six top industry insiders recently shared with "The Tan Sheet" their thoughts on the pending release of FDA's final rule on dietary supplement Good Manufacturing Practices. The participants were: Scott Bass of the law firm Sidley Austin Brown & Wood; Council for Responsible Nutrition President Annette Dickinson, PhD; Utah Natural Products Alliance Executive Director Loren Israelsen; American Herbal Products Association President Michael McGuffin; U.S. Pharmacopeia Director-Dietary Supplements David Roll, PhD; and National Nutritional Foods Association Executive Director & CEO David Seckman.

You may also be interested in...



Dietary Supplement GMP Spin-Off Reg May Address Small Business Impact

The Office of Management and Budget on May 23 completed reviewing an interim final rule related to dietary supplement good manufacturing practices FDA is expected to publish within six weeks, according to OMB.

Dietary Supplement GMP Spin-Off Reg May Address Small Business Impact

The Office of Management and Budget on May 23 completed reviewing an interim final rule related to dietary supplement good manufacturing practices FDA is expected to publish within six weeks, according to OMB.

Dietary Supplement GMP Spin-Off Reg May Address Small Business Impact

The Office of Management and Budget on May 23 completed reviewing an interim final rule related to dietary supplement good manufacturing practices FDA is expected to publish within six weeks, according to OMB.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097661

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel